Animal Pharmaceutical-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Animal Pharmaceutical-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Animal Pharmaceutical industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Animal Pharmaceutical 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Animal Pharmaceutical worldwide and market share by regions, with company and product introduction, position in the Animal Pharmaceutical market
Market status and development trend of Animal Pharmaceutical by types and applications
Cost and profit status of Animal Pharmaceutical, and marketing status
Market growth drivers and challenges
The report segments the global Animal Pharmaceutical market as:
Global Animal Pharmaceutical Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Animal Pharmaceutical Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Vaccine
Veterinary Drugs
Other
Global Animal Pharmaceutical Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Companion Animal
Poultry
Other
Global Animal Pharmaceutical Market: Manufacturers Segment Analysis (Company and Product introduction, Animal Pharmaceutical Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Merck
Merial
Elanco
Bayer Animal Health
Boehringer Ingelheim Vetmedica
Virbac
Ceva Sante Animale
V?toquinol
Jurox
MSD Animal Health Australia
PARNELL
CAHIC
Ringpu Biology
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Animal Pharmaceutical-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Animal Pharmaceutical industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Animal Pharmaceutical 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Animal Pharmaceutical worldwide and market share by regions, with company and product introduction, position in the Animal Pharmaceutical market
Market status and development trend of Animal Pharmaceutical by types and applications
Cost and profit status of Animal Pharmaceutical, and marketing status
Market growth drivers and challenges
The report segments the global Animal Pharmaceutical market as:
Global Animal Pharmaceutical Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Animal Pharmaceutical Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Vaccine
Veterinary Drugs
Other
Global Animal Pharmaceutical Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Companion Animal
Poultry
Other
Global Animal Pharmaceutical Market: Manufacturers Segment Analysis (Company and Product introduction, Animal Pharmaceutical Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Merck
Merial
Elanco
Bayer Animal Health
Boehringer Ingelheim Vetmedica
Virbac
Ceva Sante Animale
V?toquinol
Jurox
MSD Animal Health Australia
PARNELL
CAHIC
Ringpu Biology
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ANIMAL PHARMACEUTICAL
1.1 Definition of Animal Pharmaceutical in This Report
1.2 Commercial Types of Animal Pharmaceutical
1.2.1 Vaccine
1.2.2 Veterinary Drugs
1.2.3 Other
1.3 Downstream Application of Animal Pharmaceutical
1.3.1 Companion Animal
1.3.2 Poultry
1.3.3 Other
1.4 Development History of Animal Pharmaceutical
1.5 Market Status and Trend of Animal Pharmaceutical 2013-2023
1.5.1 Global Animal Pharmaceutical Market Status and Trend 2013-2023
1.5.2 Regional Animal Pharmaceutical Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Animal Pharmaceutical 2013-2017
2.2 Sales Market of Animal Pharmaceutical by Regions
2.2.1 Sales Volume of Animal Pharmaceutical by Regions
2.2.2 Sales Value of Animal Pharmaceutical by Regions
2.3 Production Market of Animal Pharmaceutical by Regions
2.4 Global Market Forecast of Animal Pharmaceutical 2018-2023
2.4.1 Global Market Forecast of Animal Pharmaceutical 2018-2023
2.4.2 Market Forecast of Animal Pharmaceutical by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Animal Pharmaceutical by Types
3.2 Sales Value of Animal Pharmaceutical by Types
3.3 Market Forecast of Animal Pharmaceutical by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Animal Pharmaceutical by Downstream Industry
4.2 Global Market Forecast of Animal Pharmaceutical by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Animal Pharmaceutical Market Status by Countries
5.1.1 North America Animal Pharmaceutical Sales by Countries (2013-2017)
5.1.2 North America Animal Pharmaceutical Revenue by Countries (2013-2017)
5.1.3 United States Animal Pharmaceutical Market Status (2013-2017)
5.1.4 Canada Animal Pharmaceutical Market Status (2013-2017)
5.1.5 Mexico Animal Pharmaceutical Market Status (2013-2017)
5.2 North America Animal Pharmaceutical Market Status by Manufacturers
5.3 North America Animal Pharmaceutical Market Status by Type (2013-2017)
5.3.1 North America Animal Pharmaceutical Sales by Type (2013-2017)
5.3.2 North America Animal Pharmaceutical Revenue by Type (2013-2017)
5.4 North America Animal Pharmaceutical Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Animal Pharmaceutical Market Status by Countries
6.1.1 Europe Animal Pharmaceutical Sales by Countries (2013-2017)
6.1.2 Europe Animal Pharmaceutical Revenue by Countries (2013-2017)
6.1.3 Germany Animal Pharmaceutical Market Status (2013-2017)
6.1.4 UK Animal Pharmaceutical Market Status (2013-2017)
6.1.5 France Animal Pharmaceutical Market Status (2013-2017)
6.1.6 Italy Animal Pharmaceutical Market Status (2013-2017)
6.1.7 Russia Animal Pharmaceutical Market Status (2013-2017)
6.1.8 Spain Animal Pharmaceutical Market Status (2013-2017)
6.1.9 Benelux Animal Pharmaceutical Market Status (2013-2017)
6.2 Europe Animal Pharmaceutical Market Status by Manufacturers
6.3 Europe Animal Pharmaceutical Market Status by Type (2013-2017)
6.3.1 Europe Animal Pharmaceutical Sales by Type (2013-2017)
6.3.2 Europe Animal Pharmaceutical Revenue by Type (2013-2017)
6.4 Europe Animal Pharmaceutical Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Animal Pharmaceutical Market Status by Countries
7.1.1 Asia Pacific Animal Pharmaceutical Sales by Countries (2013-2017)
7.1.2 Asia Pacific Animal Pharmaceutical Revenue by Countries (2013-2017)
7.1.3 China Animal Pharmaceutical Market Status (2013-2017)
7.1.4 Japan Animal Pharmaceutical Market Status (2013-2017)
7.1.5 India Animal Pharmaceutical Market Status (2013-2017)
7.1.6 Southeast Asia Animal Pharmaceutical Market Status (2013-2017)
7.1.7 Australia Animal Pharmaceutical Market Status (2013-2017)
7.2 Asia Pacific Animal Pharmaceutical Market Status by Manufacturers
7.3 Asia Pacific Animal Pharmaceutical Market Status by Type (2013-2017)
7.3.1 Asia Pacific Animal Pharmaceutical Sales by Type (2013-2017)
7.3.2 Asia Pacific Animal Pharmaceutical Revenue by Type (2013-2017)
7.4 Asia Pacific Animal Pharmaceutical Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Animal Pharmaceutical Market Status by Countries
8.1.1 Latin America Animal Pharmaceutical Sales by Countries (2013-2017)
8.1.2 Latin America Animal Pharmaceutical Revenue by Countries (2013-2017)
8.1.3 Brazil Animal Pharmaceutical Market Status (2013-2017)
8.1.4 Argentina Animal Pharmaceutical Market Status (2013-2017)
8.1.5 Colombia Animal Pharmaceutical Market Status (2013-2017)
8.2 Latin America Animal Pharmaceutical Market Status by Manufacturers
8.3 Latin America Animal Pharmaceutical Market Status by Type (2013-2017)
8.3.1 Latin America Animal Pharmaceutical Sales by Type (2013-2017)
8.3.2 Latin America Animal Pharmaceutical Revenue by Type (2013-2017)
8.4 Latin America Animal Pharmaceutical Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Animal Pharmaceutical Market Status by Countries
9.1.1 Middle East and Africa Animal Pharmaceutical Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Animal Pharmaceutical Revenue by Countries (2013-2017)
9.1.3 Middle East Animal Pharmaceutical Market Status (2013-2017)
9.1.4 Africa Animal Pharmaceutical Market Status (2013-2017)
9.2 Middle East and Africa Animal Pharmaceutical Market Status by Manufacturers
9.3 Middle East and Africa Animal Pharmaceutical Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Animal Pharmaceutical Sales by Type (2013-2017)
9.3.2 Middle East and Africa Animal Pharmaceutical Revenue by Type (2013-2017)
9.4 Middle East and Africa Animal Pharmaceutical Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL PHARMACEUTICAL
10.1 Global Economy Situation and Trend Overview
10.2 Animal Pharmaceutical Downstream Industry Situation and Trend Overview
CHAPTER 11 ANIMAL PHARMACEUTICAL MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Animal Pharmaceutical by Major Manufacturers
11.2 Production Value of Animal Pharmaceutical by Major Manufacturers
11.3 Basic Information of Animal Pharmaceutical by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Animal Pharmaceutical Major Manufacturer
11.3.2 Employees and Revenue Level of Animal Pharmaceutical Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ANIMAL PHARMACEUTICAL MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Zoetis
12.1.1 Company profile
12.1.2 Representative Animal Pharmaceutical Product
12.1.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Zoetis
12.2 Merck
12.2.1 Company profile
12.2.2 Representative Animal Pharmaceutical Product
12.2.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Merck
12.3 Merial
12.3.1 Company profile
12.3.2 Representative Animal Pharmaceutical Product
12.3.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Merial
12.4 Elanco
12.4.1 Company profile
12.4.2 Representative Animal Pharmaceutical Product
12.4.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Elanco
12.5 Bayer Animal Health
12.5.1 Company profile
12.5.2 Representative Animal Pharmaceutical Product
12.5.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Bayer Animal Health
12.6 Boehringer Ingelheim Vetmedica
12.6.1 Company profile
12.6.2 Representative Animal Pharmaceutical Product
12.6.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim Vetmedica
12.7 Virbac
12.7.1 Company profile
12.7.2 Representative Animal Pharmaceutical Product
12.7.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Virbac
12.8 Ceva Sante Animale
12.8.1 Company profile
12.8.2 Representative Animal Pharmaceutical Product
12.8.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Ceva Sante Animale
12.9 V?toquinol
12.9.1 Company profile
12.9.2 Representative Animal Pharmaceutical Product
12.9.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of V?toquinol
12.10 Jurox
12.10.1 Company profile
12.10.2 Representative Animal Pharmaceutical Product
12.10.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Jurox
12.11 MSD Animal Health Australia
12.11.1 Company profile
12.11.2 Representative Animal Pharmaceutical Product
12.11.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of MSD Animal Health Australia
12.12 PARNELL
12.12.1 Company profile
12.12.2 Representative Animal Pharmaceutical Product
12.12.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of PARNELL
12.13 CAHIC
12.13.1 Company profile
12.13.2 Representative Animal Pharmaceutical Product
12.13.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of CAHIC
12.14 Ringpu Biology
12.14.1 Company profile
12.14.2 Representative Animal Pharmaceutical Product
12.14.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Ringpu Biology
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL PHARMACEUTICAL
13.1 Industry Chain of Animal Pharmaceutical
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ANIMAL PHARMACEUTICAL
14.1 Cost Structure Analysis of Animal Pharmaceutical
14.2 Raw Materials Cost Analysis of Animal Pharmaceutical
14.3 Labor Cost Analysis of Animal Pharmaceutical
14.4 Manufacturing Expenses Analysis of Animal Pharmaceutical
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Animal Pharmaceutical in This Report
1.2 Commercial Types of Animal Pharmaceutical
1.2.1 Vaccine
1.2.2 Veterinary Drugs
1.2.3 Other
1.3 Downstream Application of Animal Pharmaceutical
1.3.1 Companion Animal
1.3.2 Poultry
1.3.3 Other
1.4 Development History of Animal Pharmaceutical
1.5 Market Status and Trend of Animal Pharmaceutical 2013-2023
1.5.1 Global Animal Pharmaceutical Market Status and Trend 2013-2023
1.5.2 Regional Animal Pharmaceutical Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Animal Pharmaceutical 2013-2017
2.2 Sales Market of Animal Pharmaceutical by Regions
2.2.1 Sales Volume of Animal Pharmaceutical by Regions
2.2.2 Sales Value of Animal Pharmaceutical by Regions
2.3 Production Market of Animal Pharmaceutical by Regions
2.4 Global Market Forecast of Animal Pharmaceutical 2018-2023
2.4.1 Global Market Forecast of Animal Pharmaceutical 2018-2023
2.4.2 Market Forecast of Animal Pharmaceutical by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Animal Pharmaceutical by Types
3.2 Sales Value of Animal Pharmaceutical by Types
3.3 Market Forecast of Animal Pharmaceutical by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Animal Pharmaceutical by Downstream Industry
4.2 Global Market Forecast of Animal Pharmaceutical by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Animal Pharmaceutical Market Status by Countries
5.1.1 North America Animal Pharmaceutical Sales by Countries (2013-2017)
5.1.2 North America Animal Pharmaceutical Revenue by Countries (2013-2017)
5.1.3 United States Animal Pharmaceutical Market Status (2013-2017)
5.1.4 Canada Animal Pharmaceutical Market Status (2013-2017)
5.1.5 Mexico Animal Pharmaceutical Market Status (2013-2017)
5.2 North America Animal Pharmaceutical Market Status by Manufacturers
5.3 North America Animal Pharmaceutical Market Status by Type (2013-2017)
5.3.1 North America Animal Pharmaceutical Sales by Type (2013-2017)
5.3.2 North America Animal Pharmaceutical Revenue by Type (2013-2017)
5.4 North America Animal Pharmaceutical Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Animal Pharmaceutical Market Status by Countries
6.1.1 Europe Animal Pharmaceutical Sales by Countries (2013-2017)
6.1.2 Europe Animal Pharmaceutical Revenue by Countries (2013-2017)
6.1.3 Germany Animal Pharmaceutical Market Status (2013-2017)
6.1.4 UK Animal Pharmaceutical Market Status (2013-2017)
6.1.5 France Animal Pharmaceutical Market Status (2013-2017)
6.1.6 Italy Animal Pharmaceutical Market Status (2013-2017)
6.1.7 Russia Animal Pharmaceutical Market Status (2013-2017)
6.1.8 Spain Animal Pharmaceutical Market Status (2013-2017)
6.1.9 Benelux Animal Pharmaceutical Market Status (2013-2017)
6.2 Europe Animal Pharmaceutical Market Status by Manufacturers
6.3 Europe Animal Pharmaceutical Market Status by Type (2013-2017)
6.3.1 Europe Animal Pharmaceutical Sales by Type (2013-2017)
6.3.2 Europe Animal Pharmaceutical Revenue by Type (2013-2017)
6.4 Europe Animal Pharmaceutical Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Animal Pharmaceutical Market Status by Countries
7.1.1 Asia Pacific Animal Pharmaceutical Sales by Countries (2013-2017)
7.1.2 Asia Pacific Animal Pharmaceutical Revenue by Countries (2013-2017)
7.1.3 China Animal Pharmaceutical Market Status (2013-2017)
7.1.4 Japan Animal Pharmaceutical Market Status (2013-2017)
7.1.5 India Animal Pharmaceutical Market Status (2013-2017)
7.1.6 Southeast Asia Animal Pharmaceutical Market Status (2013-2017)
7.1.7 Australia Animal Pharmaceutical Market Status (2013-2017)
7.2 Asia Pacific Animal Pharmaceutical Market Status by Manufacturers
7.3 Asia Pacific Animal Pharmaceutical Market Status by Type (2013-2017)
7.3.1 Asia Pacific Animal Pharmaceutical Sales by Type (2013-2017)
7.3.2 Asia Pacific Animal Pharmaceutical Revenue by Type (2013-2017)
7.4 Asia Pacific Animal Pharmaceutical Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Animal Pharmaceutical Market Status by Countries
8.1.1 Latin America Animal Pharmaceutical Sales by Countries (2013-2017)
8.1.2 Latin America Animal Pharmaceutical Revenue by Countries (2013-2017)
8.1.3 Brazil Animal Pharmaceutical Market Status (2013-2017)
8.1.4 Argentina Animal Pharmaceutical Market Status (2013-2017)
8.1.5 Colombia Animal Pharmaceutical Market Status (2013-2017)
8.2 Latin America Animal Pharmaceutical Market Status by Manufacturers
8.3 Latin America Animal Pharmaceutical Market Status by Type (2013-2017)
8.3.1 Latin America Animal Pharmaceutical Sales by Type (2013-2017)
8.3.2 Latin America Animal Pharmaceutical Revenue by Type (2013-2017)
8.4 Latin America Animal Pharmaceutical Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Animal Pharmaceutical Market Status by Countries
9.1.1 Middle East and Africa Animal Pharmaceutical Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Animal Pharmaceutical Revenue by Countries (2013-2017)
9.1.3 Middle East Animal Pharmaceutical Market Status (2013-2017)
9.1.4 Africa Animal Pharmaceutical Market Status (2013-2017)
9.2 Middle East and Africa Animal Pharmaceutical Market Status by Manufacturers
9.3 Middle East and Africa Animal Pharmaceutical Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Animal Pharmaceutical Sales by Type (2013-2017)
9.3.2 Middle East and Africa Animal Pharmaceutical Revenue by Type (2013-2017)
9.4 Middle East and Africa Animal Pharmaceutical Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL PHARMACEUTICAL
10.1 Global Economy Situation and Trend Overview
10.2 Animal Pharmaceutical Downstream Industry Situation and Trend Overview
CHAPTER 11 ANIMAL PHARMACEUTICAL MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Animal Pharmaceutical by Major Manufacturers
11.2 Production Value of Animal Pharmaceutical by Major Manufacturers
11.3 Basic Information of Animal Pharmaceutical by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Animal Pharmaceutical Major Manufacturer
11.3.2 Employees and Revenue Level of Animal Pharmaceutical Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ANIMAL PHARMACEUTICAL MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Zoetis
12.1.1 Company profile
12.1.2 Representative Animal Pharmaceutical Product
12.1.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Zoetis
12.2 Merck
12.2.1 Company profile
12.2.2 Representative Animal Pharmaceutical Product
12.2.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Merck
12.3 Merial
12.3.1 Company profile
12.3.2 Representative Animal Pharmaceutical Product
12.3.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Merial
12.4 Elanco
12.4.1 Company profile
12.4.2 Representative Animal Pharmaceutical Product
12.4.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Elanco
12.5 Bayer Animal Health
12.5.1 Company profile
12.5.2 Representative Animal Pharmaceutical Product
12.5.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Bayer Animal Health
12.6 Boehringer Ingelheim Vetmedica
12.6.1 Company profile
12.6.2 Representative Animal Pharmaceutical Product
12.6.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim Vetmedica
12.7 Virbac
12.7.1 Company profile
12.7.2 Representative Animal Pharmaceutical Product
12.7.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Virbac
12.8 Ceva Sante Animale
12.8.1 Company profile
12.8.2 Representative Animal Pharmaceutical Product
12.8.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Ceva Sante Animale
12.9 V?toquinol
12.9.1 Company profile
12.9.2 Representative Animal Pharmaceutical Product
12.9.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of V?toquinol
12.10 Jurox
12.10.1 Company profile
12.10.2 Representative Animal Pharmaceutical Product
12.10.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Jurox
12.11 MSD Animal Health Australia
12.11.1 Company profile
12.11.2 Representative Animal Pharmaceutical Product
12.11.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of MSD Animal Health Australia
12.12 PARNELL
12.12.1 Company profile
12.12.2 Representative Animal Pharmaceutical Product
12.12.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of PARNELL
12.13 CAHIC
12.13.1 Company profile
12.13.2 Representative Animal Pharmaceutical Product
12.13.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of CAHIC
12.14 Ringpu Biology
12.14.1 Company profile
12.14.2 Representative Animal Pharmaceutical Product
12.14.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Ringpu Biology
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL PHARMACEUTICAL
13.1 Industry Chain of Animal Pharmaceutical
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ANIMAL PHARMACEUTICAL
14.1 Cost Structure Analysis of Animal Pharmaceutical
14.2 Raw Materials Cost Analysis of Animal Pharmaceutical
14.3 Labor Cost Analysis of Animal Pharmaceutical
14.4 Manufacturing Expenses Analysis of Animal Pharmaceutical
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
